Cargando…
Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of S...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030209/ https://www.ncbi.nlm.nih.gov/pubmed/29968758 http://dx.doi.org/10.1038/s41598-018-28263-7 |
_version_ | 1783337100185174016 |
---|---|
author | Rexen Ulven, Elisabeth Trauelsen, Mette Brvar, Matjaz Lückmann, Michael Bielefeldt, Line Ø. Jensen, Lisa K. I. Schwartz, Thue W. Frimurer, Thomas M. |
author_facet | Rexen Ulven, Elisabeth Trauelsen, Mette Brvar, Matjaz Lückmann, Michael Bielefeldt, Line Ø. Jensen, Lisa K. I. Schwartz, Thue W. Frimurer, Thomas M. |
author_sort | Rexen Ulven, Elisabeth |
collection | PubMed |
description | The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of SUCNR1. Recently, we published the discovery of a computationally receptor-structure derived non-metabolite SUCNR1 agonist series with high target selectivity. We here report our structure-activity exploration and optimisation that has resulted in the development of agonists with nanomolar potency and excellent solubility and stability properties in a number of in vitro assays. Ligand-guided receptor models with high discriminative power between binding of active and inactive compounds were developed for design of novel chemotypes. |
format | Online Article Text |
id | pubmed-6030209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60302092018-07-11 Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1 Rexen Ulven, Elisabeth Trauelsen, Mette Brvar, Matjaz Lückmann, Michael Bielefeldt, Line Ø. Jensen, Lisa K. I. Schwartz, Thue W. Frimurer, Thomas M. Sci Rep Article The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of SUCNR1. Recently, we published the discovery of a computationally receptor-structure derived non-metabolite SUCNR1 agonist series with high target selectivity. We here report our structure-activity exploration and optimisation that has resulted in the development of agonists with nanomolar potency and excellent solubility and stability properties in a number of in vitro assays. Ligand-guided receptor models with high discriminative power between binding of active and inactive compounds were developed for design of novel chemotypes. Nature Publishing Group UK 2018-07-03 /pmc/articles/PMC6030209/ /pubmed/29968758 http://dx.doi.org/10.1038/s41598-018-28263-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Rexen Ulven, Elisabeth Trauelsen, Mette Brvar, Matjaz Lückmann, Michael Bielefeldt, Line Ø. Jensen, Lisa K. I. Schwartz, Thue W. Frimurer, Thomas M. Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1 |
title | Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1 |
title_full | Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1 |
title_fullStr | Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1 |
title_full_unstemmed | Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1 |
title_short | Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1 |
title_sort | structure-activity investigations and optimisations of non-metabolite agonists for the succinate receptor 1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030209/ https://www.ncbi.nlm.nih.gov/pubmed/29968758 http://dx.doi.org/10.1038/s41598-018-28263-7 |
work_keys_str_mv | AT rexenulvenelisabeth structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1 AT trauelsenmette structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1 AT brvarmatjaz structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1 AT luckmannmichael structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1 AT bielefeldtlineø structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1 AT jensenlisaki structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1 AT schwartzthuew structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1 AT frimurerthomasm structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1 |